HCPLive

Fred Poordad, MD, on Ethnic Differences in Telaprevir Treatment Effect

$shareThis$
In this video Fred Poordad, MD, Chief of Hepatology and Liver Transplantation at the Comprehensive Transplant Center at Cedars-Sinai Medical Center evaluates the effect of race on the response to treatment and viral resistance profiles with telaprevir combination therapy.

 

Most Popular

Recommended Reading

Physicians must decide on a case by case basis which patients will benefit the most from hepatitis C virus therapy, according to an editorial in JAMA Internal Medicine.
With the numbers of children suffering from food allergies and asthma on the rise research has turned to the inside of the body to look for clues about a possible treatment.
A veteran in the field of medicine gets a bird's eye view of life from the patient's perspective
Deaths and infections traced to duodenoscopes contaminated with carbapenem-resistant enterobacteriaceae infections are on the rise. The ECRI Institute, a nonprofit research and testing lab, today put out a "high priority hazard report" on procedures for cleaning the devices. It isn't easy.
$vacMongoViewPlus$ $vAR$